| KSR1 knockout mouse model demonstrates MAPK pathway’s key role in cisplatin-and noise-induced hearing loss MA Ingersoll, RD Lutze, RG Kelmann, DF Kresock, JD Marsh, ... Journal of Neuroscience 44 (18), 2024 | 6 | 2024 |
| Dabrafenib protects from cisplatin-induced hearing loss in a clinically relevant mouse model MA Ingersoll, RD Lutze, CK Pushpan, RG Kelmann, H Liu, MT May, ... JCI insight 8 (24), 2023 | 6 | 2023 |
| Repurposing AZD5438 and Dabrafenib for Cisplatin-Induced Acute Kidney Injury CK Pushpan, DF Kresock, MA Ingersoll, RD Lutze, DL Keirns, WJ Hunter, ... Journal of the American Society of Nephrology, 10.1681, 2023 | 6 | 2023 |
| ERK1/2 Inhibition Alleviates Noise-Induced Hearing Loss While Tempering Down the Immune Response RD Lutze, MA Ingersoll, A Thotam, A Joseph, J Fernandes, T Teitz bioRxiv, 2023 | 3 | 2023 |
| ERK1/2 Inhibition via the Oral Administration of Tizaterkib Alleviates Noise-Induced Hearing Loss While Tempering down the Immune Response RD Lutze, MA Ingersoll, A Thotam, A Joseph, J Fernandes, T Teitz International Journal of Molecular Sciences 25 (12), 6305, 2024 | 1 | 2024 |
| Trametinib, a MEK1/2 Inhibitor, Protects Mice from Cisplatin-and Noise-Induced Hearing Loss RD Lutze, MA Ingersoll, RG Kelmann, T Teitz Pharmaceuticals 17 (6), 735, 2024 | | 2024 |
| Oseltamivir (Tamiflu), a Commonly Prescribed Antiviral Drug, Mitigates Hearing Loss in Mice E Sailor-Longsworth, RD Lutze, MA Ingersoll, RG Kelmann, K Ly, ... bioRxiv, 2024 | | 2024 |
| FDA-Approved MEK1/2 Inhibitor, Trametinib, Protects Mice from Cisplatin and Noise-Induced Hearing Loss RD Lutze, MA Ingersoll, RG Kelmann, T Teitz bioRxiv, 2024.05. 20.595056, 2024 | | 2024 |
| The Role of the Mitogen Activated Protein Kinase Pathway in Cisplatin and Noise-Induced Hearing Loss RD Lutze Creighton University, 0 | | |
